Related Experiment Video
Updated: Mar 7, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
GIPC1 governed ferroptosis by regulating DECR1-modulating lipid homeostasis during dilated cardiomyopathy (DCM)
Nannan Tang1, Ruxue Mu1, He Wang1
1State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology (State Key Labratoray-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Heilongjiang, 150081, China.
Insights
Downregulated GIPC1 protein promotes ferroptosis in dilated cardiomyopathy (DCM) by impairing mitochondrial DECR1 transport. Restoring GIPC1 protects against cardiac dysfunction and ferroptosis in DCM.
Area of Science:
- Cardiology
- Cell Biology
- Biochemistry
Background:
- Dilated cardiomyopathy (DCM) is a prevalent heart condition with poorly understood ferroptosis mechanisms.
- Ferroptosis, a regulated cell death, is implicated in cardiac pathogenesis.
Purpose of the Study:
- To investigate the role of GIPC1 (GAIP/RGS19-interacting protein) in DCM pathogenesis.
- To elucidate the regulatory mechanism of ferroptosis in DCM.
Main Methods:
- Integrated proteomic and lipidomic analysis in DCM patients and models.
- In vitro and in vivo experiments using GIPC1 knockout and overexpression models.
- Co-immunoprecipitation mass spectrometry (Co-IP/MS), molecular docking, and Surface Plasmon Resonance (SPR) to study protein interactions.
- Immunofluorescence (IF) to assess protein localization.
Main Results:
- GIPC1 was significantly downregulated in DCM cardiac tissues and models.
- GIPC1 deficiency disrupted mitochondrial fatty acid metabolism, increased polyunsaturated fatty acid-containing phospholipids (PUFA-PLs), and promoted ferroptosis.
- GIPC1 interacted with DECR1 (2,4-dienoyl-CoA reductase), facilitating its mitochondrial transport and maintaining redox homeostasis.
- GIPC1 deficiency exacerbated DOX-induced cardiomyopathy, while GIPC1 overexpression conferred protection.
Conclusions:
- GIPC1 plays a protective role in DCM by suppressing ferroptosis.
- The GIPC1/DECR1 axis regulates mitochondrial translocation of DECR1, impacting lipid homeostasis and ferroptosis.
- Targeting the GIPC1/DECR1 axis offers a potential therapeutic strategy for DCM.
Abstract:
Dilated cardiomyopathy (DCM) was the most prevalent cardiomyopathy worldwide. Although ferroptosis has been implicated in cardiac pathogenesis, its regulatory mechanism in DCM remained poorly defined. In this study, we found that GIPC1 (GAIP/RGS19-interacting protein), a scaffolding protein, was significantly downregulated in cardiac tissues from DCM patients and doxorubicin (DOX)-induced DCM models. Integrated proteomic and lipidomic analysis revealed that cardiac-specific knockout of GIPC1 disrupted mitochondrial fatty acid metabolism, increased the abundance of polyunsaturated fatty acid-containing phospholipids (PUFA-PLs), and ultimately promoted ferroptosis in cardiomyocytes. Both in vitro and in vivo experiments demonstrated that GIPC1 deficiency exacerbated ferroptosis and cardiac dysfunction in DOX-induced cardiomyopathy, whereas GIPC1 overexpression conferred protection against ferroptosis in DOX-induced cardiomyopathy. Mechanistically, co-immunoprecipitation mass spectrometry (Co-IP/MS) and molecular docking demonstrated that GIPC1 interacted with mitochondrial 2,4-dienoyl-CoA reductase (DECR1) via its PDZ domain. Surface plasmon resonance (SPR) analysis further confirmed a high-affinity direct binding between GIPC1 and DECR1 (KD = 16.3 nM). Co-IP and immunofluorescence (IF) demonstrated that GIPC1 facilitated actin-dependent transport of DECR1 into mitochondria, thereby maintaining redox homeostasis and suppressing ferroptosis. Consistently, DECR1 overexpression rescued GIPC1 ablation-induced ferroptosis by balancing redox homeostasis. Together, these results demonstrated that GIPC1 reduced cardiomyocyte susceptibility to ferroptosis by promoting mitochondrial translocation of DECR1 and remodeling lipid homeostasis, highlighting GIPC1/DECR1 axis as a potential therapeutic strategy for DCM. A schematic model illustrating the pathogenic cascade triggered by GIPC1 deficiency during DCM. In DCM, the expression level of GIPC1 was downregulated, thereby inhibiting actin-dependent transport of DECR1 into mitochondria, which remodeled lipid homeostasis and ultimately induced cardiomyocytes ferroptosis. Created with Figdraw.com.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
GPCRs Regulate Adenylyl Cylase Activity
G-Protein Gated Ion Channels
Sensory...
GPCR Desensitization
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

